Suppr超能文献

覆膜支架治疗失败的血液透析通路。

Role of stent grafts for the treatment of failing hemodialysis accesses.

机构信息

Methodist DeBakey Heart and Vascular Center, Houston, TX 77030, USA.

出版信息

Semin Vasc Surg. 2011 Jun;24(2):119-27. doi: 10.1053/j.semvascsurg.2011.05.011.

Abstract

Covered stents or stent grafts are exciting new products with multiple applications for patients with vascular disease, including hemodialysis access-related complications. Although most of the current uses of stent grafts in these settings are "off-label" (ie, not approved by the US Food and Drug Administration) several studies are currently underway to provide the necessary data to support their application. It is clear that stent grafts provide a rapid, effective means for endovascular repair of ruptured access vessels. The commercially available devices and their current applications for treating access-related complications, including aneurysms/pseudoaneurysms, venous outflow stenoses, cephalic arch lesions, ruptures, and diffuse access stenoses, will be reviewed in this article. Available data are reported along with our current clinical practice and algorithms.

摘要

覆膜支架或支架移植物是具有多种血管疾病应用的令人兴奋的新产品,包括与血液透析通路相关的并发症。尽管目前在这些情况下使用支架移植物的大多数用途都是“超适应证”(即未获得美国食品和药物管理局批准),但目前正在进行多项研究,以提供必要的数据来支持其应用。很明显,支架移植物为血管内修复破裂的通路血管提供了一种快速、有效的手段。本文将回顾可用于治疗与通路相关并发症的商业上可用的设备及其当前应用,包括动脉瘤/假性动脉瘤、静脉流出道狭窄、头臂弓病变、破裂和弥漫性通路狭窄。将报告现有数据以及我们当前的临床实践和算法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验